Guntern Takes Lead At Medicines For Europe

Sandoz Executive Becomes Interim President After Teva’s Stoller Completes Two-Year Term

 
• By Dave Wallace

Sandoz’s Rebecca Guntern has been named as interim president of Medicines for Europe for a three-month term, after Teva’s Christoph Stoller stepped down at the end of his two-year tenure.

Rebecca Guntern, of Sandoz
Rebecca Guntern has taken over as interim president of the association • Source: Sandoz

More from Leadership

More from Generics Bulletin